Y-mAbs Therapeutics (NASDAQ:YMAB) Earns “Outperform” Rating from Wedbush
Y-mAbs Therapeutics (NASDAQ:YMAB – Get Free Report)‘s stock had its “outperform” rating reiterated by analysts at Wedbush in a research note issued on Friday,RTT News reports. They currently have a $23.00 price objective on the stock. Wedbush’s price target indicates a potential upside of 233.82% from the stock’s previous close. A number of other equities […]
More Stories
Is Blue Eye Samurai Season 2 Announced? Release Date, Trailer, and More
Netflix’s adult anime series, Blue Eye Samurai, first premiered in 2023 and has quickly become one of the most acclaimed...
Oasis Season 1 is Live on Netflix! Review, Rating, and Update on Season 2 Release
Netflix has released an all-new Spanish mystery thriller, Oasis, season 1. The series is full of thriller scenes and suspenseful...
Ricky Gervais’ Alley Cats Trailer is Out! Know the Release Date and Other Details
Ricky Gervais is coming back with an all-new adult animated series, Alley Cats. The theme is about the everyday life...
Better Late Than Single Season 2: Release Date, Contestants Details, Trailer, and More
Better Late Than Single is a South Korean reality show that first premiered on Netflix in July 2025. Better Late...
10 Best Animated Movies that You Can Binge-Watch on Netflix
Are you also an animation movie lover, just like me? Here, in this blog, I have mentioned some of the...
8 Best K-Dramas on Netflix for Beginners to Binge-Watch on the Weekend
Lots of Korean dramas, but confused about which one you should watch? Here, in this blog, I will share my...